TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 1nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 1nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 1nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 2nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 2nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 2nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 4nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 4nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 4nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 5nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 5nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 7nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 7nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 8nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 8nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 9nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 9nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 9nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 10nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 10nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 10nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 12nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 12nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 12nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 13nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 13nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology
US Patent
Sumitomo Dainippon Pharma Oncology
US Patent
Affinity DataIC50: 13nMT: 2°CAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair